TL;DR
- MIT45 is the most recognized name in extract shots, and the recognition is earned. This is a fair comparison, not a hit piece.
- MIT45 publishes a public, per-lot certificate of analysis library. Most of the category does not. Credit where it's due, and we're not going to pretend otherwise to make ourselves look better.
- Their lineup: Gold (250 mg extract, ~125 mg mitragynine, 15 ml), Super K (500 mg extract, ~150 mg mitragynine, 30 ml), Super K Extra Strong (1,250 mg extract, ~375 mg mitragynine, 30 ml).
- Compare milligrams of mitragynine, not milligrams of "extract." Those are different numbers and the gap between them is large.
- Reading MIT45's published COAs side by side reveals something their marketing doesn't say: the alkaloid ratios in Gold and Extra Strong are nearly identical. The difference is concentration, not spectrum.
- We sell competing products. Bias disclosed, every number below checkable against public documents.
Why This Comparison Is Worth Doing Honestly
MIT45 is the brand most people picture when they hear "kratom shot." It's in more stores, on more counters, and in more shopping carts than anything else in the format.
Comparing yourself to the category leader is a trap when you sell against them. The temptation is to build a scoring rubric that just happens to favor your own products, then declare victory. Readers see through it, and they should.
So here's the approach. Every criterion is stated before the comparison starts. Every number comes from published product information or published lab documents you can open yourself. And where MIT45 is the better choice, this article says so.
Starting with the biggest one: MIT45 publishes per-lot COAs in a public library, roughly three dozen documents covering finished products and raw ingredients, retrievable without asking anyone. That puts them ahead of most of this industry, including several brands that market themselves on transparency. Any comparison that skipped that fact would be dishonest.
The MIT45 Lineup, Decoded
MIT45 sells more SKUs than most buyers realize, and the naming doesn't make the hierarchy obvious.
| Product | Bottle | Extract | Mitragynine | Positioning |
|---|---|---|---|---|
| Gold | 15 ml | 250 mg | ~125 mg | The flagship |
| Super K | 30 ml | 500 mg | ~150 mg | Marketed as the calmer option |
| Super K Extra Strong | 30 ml | 1,250 mg | ~375 mg | Purple bottle, the high-ceiling option |
| Boost / Go / gummies | Varies | Varies | Varies | Portable formats, line extensions |
One labeling note worth flagging, because it trips people up. MIT45's own materials describe Gold both as "45% mitragynine" and as delivering 125 mg from 250 mg of extract. Those two statements can't both be current, since 250 x 45% is 112.5 mg. The company's site resolves it: the 112.5 mg figure is the old formula and the new packaging delivers 125 mg, roughly 10% more. The "45%" is legacy label copy. Their published COA for one Gold lot measured 126.16 mg of mitragynine per package, which lines up with the newer number.
That's not a gotcha. It's a normal artifact of a reformulation working its way through packaging. But it's a good illustration of why the COA beats the label when the two disagree.
The Number That Actually Matters
This is the detail that trips up nearly every shot buyer.
"500 mg of extract" and "500 mg of mitragynine" are completely different claims, and the gap between them is enormous. Super K contains 500 mg of extract, of which roughly 150 mg is mitragynine. The extract number is more than three times larger than the alkaloid number.
Both numbers are honest. Neither is a lie. But if you compare one brand's extract weight against another brand's alkaloid weight, you will reach a completely wrong conclusion about which is stronger.
So the rule when comparing any two shots: find the mitragynine figure in milligrams, and compare only that. If a brand doesn't publish it, that absence is itself information. MIT45 does publish it, which is what makes this comparison possible at all.
What MIT45's Own Lab Reports Reveal
Since the COAs are public, the useful thing to do is actually read them rather than describe them.
Two things stand out. First, measured content runs close to or slightly above label claim. The Gold lot measured 126.16 mg against a 125 mg claim. An Extra Strong lot measured 395.68 mg against a ~375 mg claim. Both land on the generous side of label. That's the direction you'd rather see, though it does mean a "quarter bottle" is a slightly bigger dose than the arithmetic suggests.
Second, and this is the part worth the click, the COAs break out individual alkaloids rather than reporting a single total. That means you can put two products side by side and compare what's actually in them instead of comparing how each one is described on the bottle.
| Alkaloid, as % of total | MIT45 Gold | Super K Extra Strong |
|---|---|---|
| Mitragynine | 70.8% | 69.6% |
| Paynantheine | 14.3% | 14.1% |
| Speciociliatine | 7.6% | 8.9% |
| Speciogynine | 7.3% | 7.4% |
For practical purposes those are the same material at two concentrations.
The Marketing Claim Their COAs Don't Support
Which brings us to the one substantive criticism in this review, and it's a narrow one.
You'll frequently see it said, including in secondhand write-ups of the brand, that Super K is calmer than Gold because it carries a broader alkaloid spectrum. The calmer part is MIT45's own positioning and plenty of users agree with it. The broader-spectrum explanation is the part their published lab data doesn't back up. As the table above shows, the alkaloid ratios track within about a percentage point of each other.
MIT45's own FAQ actually gives the more defensible explanation: Super K is a lower mitragynine concentration per unit of extract than Gold. Less concentrated, so a gentler profile. That holds up fine. The spectrum framing is the part that doesn't, and it seems to be marketing language that outran the chemistry rather than an intentional misstatement.
We're pointing this out for a reason beyond scoring a point: this is what published COAs are for. When a company posts its lab data, claims become checkable. That's an argument for more disclosure across the industry, including the brands that would rather not be checked.
Head to Head
| Criteria | MIT45 | King K |
|---|---|---|
| Format range | Shots, gummies, portable formats | Liquid extracts, tablets, energy shots |
| Mitragynine published | Yes, per product | Yes, per product |
| Batch COAs | Public per-lot library | Published on the lab results page |
| Potency ceiling | Very high (~375 mg in Extra Strong) | Moderate by design |
| Extract philosophy | Concentration-forward | Natural full-spectrum only, no synthesized alkaloids |
| Retail availability | Extremely wide | Online and select retail |
Read that honestly and the split is clear. MIT45 wins on reach and on ceiling, and matches us on disclosure. Our differentiation is narrower than we might like it to be: it's chemistry philosophy and product range, not paperwork.
Extraction Approach: Concentration Versus Spectrum
This is where the two brands genuinely diverge, and it isn't a matter of one being better at the same thing.
Concentration-forward extraction pushes the mitragynine percentage as high as possible. You get a predictable, potent, mitragynine-dominant product.
Full-spectrum extraction concentrates the leaf's whole alkaloid profile while keeping natural ratios roughly intact. You get somewhat less mitragynine per milligram, and you keep the minor alkaloids that shape how the material behaves.
Kratom leaf contains roughly 54 identified alkaloids, and research into how the minor ones contribute is genuinely early. A pharmacological characterization of minor kratom alkaloids published in PMC found that several of these compounds are pharmacologically active in their own right, which is a reason to take the distinction seriously without overclaiming what it delivers. A 2022 review in Frontiers in Pharmacology covers the chemistry in more depth, including how much alkaloid content varies by growing region.
Neither approach is wrong. They're optimized for different outcomes. King K sits entirely on the full-spectrum side, and the reason is partly chemistry and partly regulatory durability. The DEA currently lists kratom as a "Drug of Concern" rather than a scheduled substance, and its July 2026 notice of intent targets concentrated 7-hydroxymitragynine above a defined threshold rather than the plant broadly. Products that isolate or amplify a single alkaloid past natural ratios are exactly what that enforcement attention is aimed at. Staying inside natural ratios is a business-continuity decision as much as a product one.
Price Per Milligram, Not Price Per Bottle
Shot pricing confuses people because bottle size and potency both move at once. One calculation fixes it.
Divide the bottle price by the milligrams of mitragynine. That gives you cost per milligram, the only number that lets you compare a 125 mg bottle against a 375 mg bottle fairly.
Run it and something counterintuitive shows up: the highest-potency options usually deliver the lowest cost per milligram. Extra Strong at ~375 mg will typically beat Gold at ~125 mg on that basis.
The math is real. It's also a trap. Cost per milligram only means something if you actually want that many milligrams. Buy a 375 mg bottle to save on unit cost, then pour portions you can't measure, and you've escalated your dose without deciding to. A cheap milligram is worthless if it carries you past where you meant to stop.
Our position, stated plainly: buy the potency that matches your intended serving, then compare cost per milligram within that tier. Never let the unit-cost math choose your dose.
What Users Report About Each
Community feedback on MIT45 runs positive and stays consistent. Strong effects. Reliable availability. Predictable bottle to bottle. Gold gets described as more energetic, Super K as smoother. The most common complaint is price, and the second most common is that the high-potency options are easy to overdo, which is a category-wide issue rather than a brand defect.
Feedback on King K's extracts centers on the flavor being more tolerable than expected and on the published numbers making dose planning easier. The recurring criticism is that we don't offer anything at the very top of the potency range, which is accurate and deliberate.
Worth naming honestly: heavy daily use of any concentrated extract builds tolerance faster than leaf does. That's true of MIT45 products, true of ours, and true of everything in the format.
Where MIT45 Wins Outright
Four of them, and we're not going to hedge:
- Public per-lot COA library. Roughly three dozen documents, searchable, no request required. This is the industry standard other brands should be held to.
- Availability. You can find MIT45 almost anywhere kratom is sold. No online vendor matches that convenience when you need something today.
- Potency ceiling. If you specifically want a ~375 mg mitragynine option, King K does not make one. Extra Strong exists and we don't have an answer to it.
- Transparent alkaloid labeling. They publish the mitragynine number rather than hiding behind extract weight, which is more than a lot of the category does.
A comparison from a competitor that couldn't name four genuine advantages wouldn't be worth reading.
Where King K Wins
- Chemistry consistency. Natural full-spectrum only, with no synthesized, isolated, or boosted alkaloids anywhere in the line.
- Regulatory durability. Products built on natural alkaloid ratios sit outside where enforcement has been heading.
- Tiering built for control. Silver, Gold, and Platinum ladder upward in steps designed for finding your level rather than maximizing a ceiling.
- Format range beyond shots. Pressed tablets and liquid extracts alongside the energy shots, so the same standard covers more of a rotation.
Note that "we publish our lab results" is not on this list, because MIT45 does too. It's a reason to buy from either of us over most of the market, not a reason to pick between us.
Three Buyers, Three Answers
You want it tonight and there's a smoke shop nearby. Buy MIT45. Availability is a real feature and we're not going to pretend otherwise.
You want the strongest thing available. MIT45 Super K Extra Strong, and please treat 375 mg with the seriousness that number deserves. Measure the portion, don't stack, don't mix.
You want natural full-spectrum with no isolated alkaloids, at a dose you can control. That's the case we built King K around. Compare our published lab results against theirs, then judge on the documents rather than on either company's description of itself.
FAQ
How much mitragynine is in MIT45 Gold?
Current MIT45 Gold contains 250 mg of kratom extract in a 15 ml bottle delivering about 125 mg of mitragynine. Older packaging listed 112.5 mg from a 45% concentration; the newer formula is roughly 10% stronger, and a published company COA measured 126.16 mg for one lot.
What's the difference between MIT45 Gold and Super K?
Super K contains more total extract (500 mg vs 250 mg) and more total mitragynine (~150 mg vs ~125 mg) but at a lower concentration per unit of extract, which is why it's described as the calmer option. Their published COAs show near-identical alkaloid ratios, so the difference is concentration rather than a different alkaloid spectrum.
Does MIT45 publish lab results?
Yes. MIT45 maintains a public certificate of analysis library organized by lot number, covering finished products and raw ingredients. You don't need to request anything.
Is MIT45 stronger than King K?
At the top of the range, yes. Super K Extra Strong carries roughly 375 mg of mitragynine, above anything in the King K lineup. Whether stronger is better depends entirely on the serving you actually want.
Why compare mitragynine instead of extract milligrams?
Because extract weight includes everything in the concentrate, not just the active alkaloid. Super K's 500 mg of extract yields about 150 mg of mitragynine. Comparing extract weight against alkaloid weight across brands produces badly wrong conclusions.
Final Verdict
- MIT45 leads the format for good reasons: availability, range, honest alkaloid labeling, and a public per-lot COA library.
- Compare mitragynine milligrams, never extract milligrams. That one habit prevents most bad purchases in this category.
- Read the COA when it disagrees with the label. On MIT45 Gold, the two currently tell slightly different stories and the COA is the reliable one.
- The real divide between these brands is philosophical: concentration-forward versus natural full-spectrum. It is not a transparency gap.
- Pick the philosophy that matches how you buy, then hold whichever brand you choose to its own published numbers.
If natural full-spectrum with no isolated alkaloids is the standard you want, browse the King K range or start with the King K Gold liquid extract, and check it against the lab documents before you decide.
Product specifications and lab figures reflect MIT45's publicly published product pages and certificate of analysis library as of July 2026, and can change without notice. Verify current formulations and lot documents directly with the brand before purchase. This is education, not medical advice. These statements have not been evaluated by the FDA.

